Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Friday, July 31, 2026.
Reported quarterly profit margin; no daily interpolation. Q3 FY2026 (2026-07-31): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+100.00%
vs the sector median at left
enGene Holdings Inc.
Market Cap
$121.12M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$121.05M
Net Profit Margin
-490.71%
TTM Avg
-538.75%
3Y Avg
-569.71%
5Y Avg
-1398.02%
Market Cap
$120.30M
Net Profit Margin
-7723.97%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$122.13M
Net Profit Margin
-2258.89%
TTM Avg
-4695.34%
3Y Avg
-8719.58%
5Y Avg
-5863.11%
Market Cap
$119.30M
Net Profit Margin
-586.74%
TTM Avg
-215.13%
3Y Avg
-125.58%
5Y Avg
-83.72%
Market Cap
$118.41M
Net Profit Margin
0.00%
TTM Avg
-539.97%
3Y Avg
-388.73%
5Y Avg
-259.15%
Market Cap
$112.28M
Net Profit Margin
-52.59%
TTM Avg
-29.17%
3Y Avg
-18.36%
5Y Avg
-9.63%
Market Cap
$125.09M
Net Profit Margin
-548.64%
TTM Avg
-1117.24%
3Y Avg
-934.06%
5Y Avg
-622.71%
Market Cap
$115.88M
Net Profit Margin
-270.22%
TTM Avg
-342.92%
3Y Avg
-204.73%
5Y Avg
-136.49%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| enGene Holdings Inc. (ENGN) | $121.12M | 0.00% | 0.00% | 0.00% | 0.00% |
| Seer, Inc. (SEER)vs › | $121.05M | -490.71% | -538.75% | -569.71% | -1398.02% |
| Tenaya Therapeutics, Inc. (TNYA)vs › | $120.30M | -7723.97% | 0.00% | 0.00% | 0.00% |
| Cibus, Inc. (CBUS)vs › | $122.13M | -2258.89% | -4695.34% | -8719.58% | -5863.11% |
| LENZ Therapeutics, Inc. (LENZ)vs › | $119.30M | -586.74% | -215.13% | -125.58% | -83.72% |
| Spruce Biosciences, Inc. (SPRB)vs › | $118.41M | 0.00% | -539.97% | -388.73% | -259.15% |
| BGM Group Ltd. (BGM)vs › | $112.28M | -52.59% | -29.17% | -18.36% | -9.63% |
| Tonix Pharmaceuticals Holding Corp. (TNXP)vs › | $125.09M | -548.64% | -1117.24% | -934.06% | -622.71% |
| Coya Therapeutics, Inc. (COYA)vs › | $115.88M | -270.22% | -342.92% | -204.73% | -136.49% |
| TuHURA Biosciences, Inc. (HURA)vs › | $125.14M | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-07-31 | 0.00% |
| 2026-04-30 | 0.00% |
| 2026-01-31 | 0.00% |
| 2025-10-31 | 0.00% |
| 2025-07-31 | 0.00% |
| 2025-04-30 | 0.00% |
| 2025-01-31 | 0.00% |
| 2024-10-31 | 0.00% |
| 2024-07-31 | 0.00% |
| 2024-04-30 | 0.00% |
| 2024-01-31 | 0.00% |
| 2023-10-31 | 0.00% |
| 2023-07-31 | 0.00% |
| 2023-04-30 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-10-31 | 0.00% |
| 2022-07-31 | 0.00% |
| 2022-04-30 | 0.00% |
| 2021-12-31 | 0.00% |
